They also showed a trend to a lower compliance in diabetic versus neovascular age-related macular degeneration (nAMD) patients: only 16.8% of nAMD patients were lost to follow-up at one year versus 25.45% in diabetic patients.
1
—
—
They also showed a trend to a lower compliance in diabetic versus neovascular age-related macular degeneration (nAMD) patients: only 16.8% of nAMD patients were lost to follow-up at one year versus 25.45% in diabetic patients.